LTIP903A - Preparation process of solid pharmaceutical forms and such forms - Google Patents
Preparation process of solid pharmaceutical forms and such formsInfo
- Publication number
- LTIP903A LTIP903A LTIP903A LTIP903A LTIP903A LT IP903 A LTIP903 A LT IP903A LT IP903 A LTIP903 A LT IP903A LT IP903 A LTIP903 A LT IP903A LT IP903 A LTIP903 A LT IP903A
- Authority
- LT
- Lithuania
- Prior art keywords
- forms
- solid pharmaceutical
- preparation process
- ebselen
- pharmaceutical forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
- C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D293/12—Selenazoles; Hydrogenated selenazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
Solid pharmaceutical compositions containing 2-phenyl-1,2-benzisoselenazol-3(2H)-one (EBSELEN) with high bioavailability thereof contain EBSELEN in the form of micronised crystals of EBSELEN and are prepared as described.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873720493 DE3720493A1 (en) | 1987-06-20 | 1987-06-20 | MEDICINAL PREPARATIONS WITH MICRONIZED EBSELEN CRYSTALS |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP903A true LTIP903A (en) | 1995-03-27 |
LT3669B LT3669B (en) | 1996-01-25 |
Family
ID=6330016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP903A LT3669B (en) | 1987-06-20 | 1993-08-30 | Preparation process of solid pharmaceutical forms and such forms |
Country Status (25)
Country | Link |
---|---|
US (1) | US5021242A (en) |
EP (1) | EP0296389B1 (en) |
JP (1) | JPH0713016B2 (en) |
KR (1) | KR970005322B1 (en) |
AT (1) | ATE69165T1 (en) |
AU (1) | AU603454B2 (en) |
CA (1) | CA1310906C (en) |
DD (1) | DD271056A5 (en) |
DE (2) | DE3720493A1 (en) |
DK (1) | DK173628B1 (en) |
ES (1) | ES2041736T3 (en) |
FI (1) | FI88256C (en) |
GE (1) | GEP19960342B (en) |
GR (1) | GR3003084T3 (en) |
HU (1) | HU200096B (en) |
IE (1) | IE63512B1 (en) |
LT (1) | LT3669B (en) |
LV (1) | LV10381B (en) |
MX (1) | MX169170B (en) |
NO (1) | NO175133C (en) |
NZ (1) | NZ225066A (en) |
PT (1) | PT87767B (en) |
RU (1) | RU1834657C (en) |
UA (1) | UA12648A (en) |
ZA (1) | ZA884025B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5368864A (en) * | 1988-11-25 | 1994-11-29 | Henning Berlin Gmbh Chemie- Und Pharmawerk | Formulation of oxypurinol and/or its alkali and alkaline earth salts |
FR2684298B1 (en) * | 1991-12-03 | 1994-03-11 | Rhone Poulenc Rorer Sa | NOVEL SOLID PHARMACEUTICAL COMPOSITIONS BASED ON 1,4-SUBSTITUTED LAPIPERIDINE DERIVATIVES. |
JP2553434B2 (en) * | 1992-04-28 | 1996-11-13 | 第一製薬株式会社 | Granular formulation |
US6335036B1 (en) * | 1993-10-27 | 2002-01-01 | Daiichi Pharmaceutical Co., Ltd. | Granular pharmaceutical preparation of ebselen |
US5609883A (en) * | 1994-09-16 | 1997-03-11 | Advanced Technology Pharmaceuticals Corporation | Compressed tablet transitory lubricant system |
US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
MX9706449A (en) * | 1995-02-28 | 1997-11-29 | Hoechst Marion Roussel Inc | Pharmaceutical composition for piperidinoalkanol compounds. |
WO1999009957A1 (en) * | 1997-08-26 | 1999-03-04 | Hoechst Marion Roussel, Inc. | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
WO2000058281A1 (en) | 1999-03-31 | 2000-10-05 | Daiichi Pharmaceutical Co., Ltd. | Substrates for thioredoxin reductase |
AU4239302A (en) * | 2001-06-28 | 2003-01-02 | Pfizer Products Inc. | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
US20040048931A1 (en) * | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
CA2511992A1 (en) * | 2003-02-24 | 2004-09-10 | Mallinckrodt Inc. | Process for preparing benzhydrylthioacetamide |
US20040253308A1 (en) * | 2003-04-29 | 2004-12-16 | Barr Laboratories, Inc. | Surface-treated modafinil particles |
US20080181966A1 (en) * | 2006-10-18 | 2008-07-31 | Cephalon, Inc. | Modafinil pharmaceutical compositions |
WO2008148064A1 (en) * | 2007-05-23 | 2008-12-04 | Sunesis Pharmaceuticals, Inc. | Weight loss treatment |
GB201102248D0 (en) | 2011-02-09 | 2011-03-23 | Isis Innovation | Treatment of bipolar disorder |
US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
TW201613888A (en) | 2014-09-26 | 2016-04-16 | Helsinn Healthcare Sa | Crystalline forms of an NK-1 antagonist |
WO2022167778A1 (en) * | 2021-02-02 | 2022-08-11 | Haiku Therapeutics Ltd | Ebselen as adenosine receptor modulator |
WO2023240092A1 (en) * | 2022-06-06 | 2023-12-14 | Sound Pharmaceuticals Inc. | Ebselen containing oral dosage forms |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3027073C2 (en) * | 1980-07-17 | 1985-03-07 | A. Nattermann & Cie GmbH, 5000 Köln | Pharmaceutical preparations containing 2-phenyl-1,2-benzisoselenazol-3 (2H) -one |
DE3407511A1 (en) * | 1984-03-01 | 1985-09-05 | A. Nattermann & Cie GmbH, 5000 Köln | BENZISOSELENAZOLTHIONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
DE3616923A1 (en) * | 1986-05-20 | 1987-11-26 | Nattermann A & Cie | NEW PHARMACEUTICAL USE OF 2-PHENYL-1,2-BENZISOSELENAZOLE-3 (2H) -ON |
DE3620674A1 (en) * | 1986-06-20 | 1987-12-23 | Nattermann A & Cie | Ointment for the treatment of skin diseases |
-
1987
- 1987-06-20 DE DE19873720493 patent/DE3720493A1/en not_active Withdrawn
-
1988
- 1988-05-30 IE IE162888A patent/IE63512B1/en not_active IP Right Cessation
- 1988-06-01 AT AT88108767T patent/ATE69165T1/en not_active IP Right Cessation
- 1988-06-01 DE DE8888108767T patent/DE3866033D1/en not_active Expired - Lifetime
- 1988-06-01 EP EP88108767A patent/EP0296389B1/en not_active Expired - Lifetime
- 1988-06-01 ES ES88108767T patent/ES2041736T3/en not_active Expired - Lifetime
- 1988-06-06 ZA ZA884025A patent/ZA884025B/en unknown
- 1988-06-14 CA CA000569410A patent/CA1310906C/en not_active Expired - Lifetime
- 1988-06-14 NO NO882615A patent/NO175133C/en not_active IP Right Cessation
- 1988-06-15 KR KR1019880007178A patent/KR970005322B1/en not_active IP Right Cessation
- 1988-06-16 MX MX011927A patent/MX169170B/en unknown
- 1988-06-17 HU HU883120A patent/HU200096B/en unknown
- 1988-06-17 NZ NZ225066A patent/NZ225066A/en unknown
- 1988-06-17 DK DK198803333A patent/DK173628B1/en not_active IP Right Cessation
- 1988-06-17 UA UA4355988A patent/UA12648A/en unknown
- 1988-06-17 FI FI882912A patent/FI88256C/en active IP Right Grant
- 1988-06-17 RU SU884355988A patent/RU1834657C/en active
- 1988-06-17 AU AU18116/88A patent/AU603454B2/en not_active Expired
- 1988-06-17 DD DD88316885A patent/DD271056A5/en unknown
- 1988-06-17 PT PT87767A patent/PT87767B/en not_active IP Right Cessation
- 1988-06-17 JP JP63148414A patent/JPH0713016B2/en not_active Expired - Lifetime
- 1988-06-20 US US07/209,325 patent/US5021242A/en not_active Expired - Lifetime
-
1991
- 1991-11-07 GR GR91401696T patent/GR3003084T3/en unknown
-
1993
- 1993-01-15 LV LVP-93-32A patent/LV10381B/en unknown
- 1993-08-17 GE GEAP19931457A patent/GEP19960342B/en unknown
- 1993-08-30 LT LTIP903A patent/LT3669B/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTIP903A (en) | Preparation process of solid pharmaceutical forms and such forms | |
GR3004925T3 (en) | ||
PT86819A (en) | PROCESS FOR THE PREPARATION OF NOVEL INSULIN DERIVATIVES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
YU211087A (en) | Process for obtaining new n-substituted benzimidazolic derivatives | |
AU583166B2 (en) | Oral garlic preparations and process for preparing same | |
DE2961394D1 (en) | 1-oxo-1h-pyrimido (6,1-b) benzothiazole derivatives, processes for their preparation and pharmaceutical compositions containing them | |
HUT47600A (en) | Process for production of encephalinase glykopeptids, amin acid derivatives with hindering effect and medical compositions containing them | |
PT81954A (en) | Process for the preparation of pharmaceutical compositions containing 9,10-dihydro alkalloids of ergot | |
IL60025A (en) | Process for the preparation of 1,3,7-tri substituted xanthines and certain new such xanthines and pharmaceutical compositions containing them | |
HUT45972A (en) | Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers | |
DE3068585D1 (en) | Derivatives of 3,4,5-trihydroxypiperidine, processes for their preparation, and their use as medicines and in animal food | |
HUT50762A (en) | Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance | |
AU597090B2 (en) | 2-acyloxypropylamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
PT76870B (en) | Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them | |
IL57939A (en) | Pharmaceutical compositions containing n-substituted aziridine-2-carboxylic acid derivatives,some such novel compounds and processes for the preparation of said n-substituted aziridine-2-carboxylic acid derivatives | |
IL82925A0 (en) | Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them | |
PT84466A (en) | Process for preparing aryl-azolylmethyl-benzocycloalkene derivatives and of pharmaceutical and fungicidal compositions containing the same | |
IL88342A (en) | Derivatives of cysteine, process for their preparation and pharmaceutical compositions containing them | |
HUT49145A (en) | Process for production of 14,15 substituated ianosterins and medical compositions containing them as active substance | |
PT77946A (en) | Process for preparing substituted carboxi-thiazolo<3,2-a>pyrimidine derivatives and of pharmaceutical compositions containing the same | |
DE2965783D1 (en) | Monochlorcitric acid derivatives, pharmaceutical compositions containing them and process for the preparation of these derivatives | |
AU6740187A (en) | Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same | |
EP0015544A3 (en) | Derivatives of the mercaptopropionamido-acetic acid, process for the preparation thereof and compositions | |
GR850484B (en) | ||
HUT47286A (en) | Process for producing benzylaminoaryl-dihydropyridine-lactones and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Expiry of a patent |
Effective date: 20130830 |